| Primary |
| Pain |
30.7% |
| Product Used For Unknown Indication |
11.2% |
| Back Pain |
11.0% |
| Drug Use For Unknown Indication |
7.0% |
| Ill-defined Disorder |
6.4% |
| Breakthrough Pain |
5.3% |
| Fibromyalgia |
4.0% |
| Depression |
3.5% |
| Hypertension |
2.3% |
| Anxiety |
2.1% |
| Intervertebral Disc Protrusion |
1.9% |
| Neuralgia |
1.9% |
| Headache |
1.8% |
| Muscle Spasms |
1.8% |
| Sleep Disorder |
1.8% |
| Diabetes Mellitus |
1.7% |
| Cancer Pain |
1.6% |
| Muscle Relaxant Therapy |
1.4% |
| Arthritis |
1.3% |
| Arthralgia |
1.2% |
|
| Wrong Technique In Drug Usage Process |
21.0% |
| Product Adhesion Issue |
11.5% |
| Product Quality Issue |
7.6% |
| Drug Dose Omission |
5.7% |
| Pain |
5.7% |
| Withdrawal Syndrome |
5.3% |
| Inappropriate Schedule Of Drug Administration |
5.0% |
| Drug Administered At Inappropriate Site |
4.6% |
| Somnolence |
4.6% |
| Drug Ineffective |
3.4% |
| Therapeutic Response Decreased |
3.4% |
| Vomiting |
3.4% |
| Death |
3.1% |
| Drug Prescribing Error |
2.7% |
| Headache |
2.7% |
| Expired Drug Administered |
2.3% |
| Treatment Noncompliance |
2.3% |
| Hyperhidrosis |
1.9% |
| Intentional Drug Misuse |
1.9% |
| Pharmaceutical Product Complaint |
1.9% |
|
| Secondary |
| Pain |
25.9% |
| Back Pain |
11.9% |
| Product Used For Unknown Indication |
8.6% |
| Ill-defined Disorder |
7.6% |
| Breakthrough Pain |
6.7% |
| Fibromyalgia |
5.2% |
| Drug Use For Unknown Indication |
4.2% |
| Depression |
3.0% |
| Intervertebral Disc Protrusion |
3.0% |
| Musculoskeletal Pain |
2.9% |
| Pain In Extremity |
2.9% |
| Arthritis |
2.5% |
| Headache |
2.2% |
| Arthralgia |
2.0% |
| Muscle Spasms |
2.0% |
| Neck Pain |
2.0% |
| Crohn's Disease |
2.0% |
| Sleep Disorder |
2.0% |
| Neuralgia |
1.7% |
| Muscle Relaxant Therapy |
1.6% |
|
| Product Adhesion Issue |
12.9% |
| Wrong Technique In Drug Usage Process |
10.6% |
| Insomnia |
7.4% |
| Headache |
6.5% |
| Product Quality Issue |
6.5% |
| Somnolence |
5.5% |
| Vision Blurred |
5.5% |
| Pain |
5.1% |
| Therapeutic Response Decreased |
5.1% |
| Withdrawal Syndrome |
4.6% |
| Memory Impairment |
4.1% |
| Vomiting |
4.1% |
| Drug Ineffective |
3.2% |
| Loss Of Consciousness |
3.2% |
| Dementia |
2.8% |
| Hyperhidrosis |
2.8% |
| Mental Status Changes |
2.8% |
| Sensory Loss |
2.8% |
| Depression |
2.3% |
| Drug Administered At Inappropriate Site |
2.3% |
|
| Concomitant |
| Product Used For Unknown Indication |
20.9% |
| Pain |
16.9% |
| Multiple Myeloma |
16.7% |
| Hypertension |
6.1% |
| Metastases To Bone |
3.8% |
| Anxiety |
3.7% |
| Breast Cancer |
3.2% |
| Depression |
3.2% |
| Hormone Replacement Therapy |
2.7% |
| Deep Vein Thrombosis |
2.4% |
| Gastrooesophageal Reflux Disease |
2.4% |
| Hiccups |
2.4% |
| Insomnia |
2.4% |
| Menopause |
2.4% |
| Nuclear Magnetic Resonance Imaging |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Osteoporosis |
2.1% |
| Imaging Procedure |
1.6% |
| Breast Cancer Metastatic |
1.3% |
| Nuclear Magnetic Resonance Imaging Brain |
1.3% |
|
| Breast Cancer |
10.0% |
| Arteriosclerosis |
8.3% |
| Cervical Spinal Stenosis |
8.3% |
| Pathological Fracture |
8.3% |
| Pneumonia |
6.7% |
| Fall |
5.0% |
| Multiple Myeloma |
5.0% |
| Urinary Retention |
5.0% |
| Urinary Tract Infection |
5.0% |
| White Blood Cell Count Decreased |
5.0% |
| Anaemia |
3.3% |
| Cholangitis |
3.3% |
| Constipation |
3.3% |
| Headache |
3.3% |
| Herpes Simplex Serology Positive |
3.3% |
| Intervertebral Disc Degeneration |
3.3% |
| Malaise |
3.3% |
| Myalgia |
3.3% |
| Myopathy |
3.3% |
| Nausea |
3.3% |
|
